Valeo Financial Advisors’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-1,801
Closed -$108K – 1916
2021
Q1
$108K Hold
1,801
– – 0.01% 591
2020
Q4
$90K Hold
1,801
– – ﹤0.01% 603
2020
Q3
$92K Sell
1,801
-2,911
-62% -$122K 0.01% 490
2020
Q2
$165K Buy
4,712
+2,911
+162% +$100K 0.02% 362
2020
Q1
$51K Hold
1,801
– – 0.01% 603
2019
Q4
$50K Buy
1,801
+980
+119% +$23.4K ﹤0.01% 654
2019
Q3
$22K Buy
821
+38
+5% +$1.32K ﹤0.01% 829
2019
Q2
$32K Buy
+783
New +$22K ﹤0.01% 724

Other funds holding AXNX

Valeo Financial Advisors's AXNX Position: Q2 2021 in Review

Valeo Financial Advisors sold out of Axonics, Inc. Common Stock (AXNX) in Q2 2021, closing a stake of 1,801 shares — an estimated $108K sold.

Valeo Financial Advisors first reported a position in AXNX in Q2 2019 and held it in 8 quarters. The position peaked at $165K in Q2 2020. 177 funds tracked by Wall St. Rank hold AXNX as of Q2 2021.

  • Valeo Financial Advisors reported no remaining Axonics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Valeo Financial Advisors sold 1,801 Axonics, Inc. Common Stock shares in Q2 2021, an estimated $108K.
  • Valeo Financial Advisors first reported a position in Axonics, Inc. Common Stock in Q2 2019 and held it in 8 quarters.
  • Valeo Financial Advisors's Axonics, Inc. Common Stock position peaked at $165K in Q2 2020.
  • 177 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q2 2021.

Based on Valeo Financial Advisors's 13F filing for Q2 2021, filed 22 Jul 2021.